Overview of the changing paradigm in cancer treatment: Oral chemotherapy
Author:
Affiliation:
1. the University of Medicine and Dentistry of New Jersey (UMDNJ)-Robert Wood Johnson Medical School, and Chief, Medical Oncology, the Cancer Institute of New Jersey, 195 Little Albany Street, Room 2012, New Brunswick, NJ 08903-2681
Publisher
Oxford University Press (OUP)
Subject
Health Policy,Pharmacology
Link
http://academic.oup.com/ajhp/article-pdf/64/9_Supplement_5/S4/28326606/ajhp000s4.pdf
Reference21 articles.
Cited by 124 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Implantation of In Situ Gelling Systems for the Delivery of Chemotherapeutic Agents;Gels;2024-01-05
2. Examination of Articles on Oral Chemotherapy in the Field of Nursing in the Last 10 Years in Türkiye;Ordu Üniversitesi Hemşirelik Çalışmaları Dergisi;2023-10-15
3. Extemporaneous compounding of dabrafenib and trametinib for cancer patients with feeding tubes;Journal of Oncology Pharmacy Practice;2023-05-08
4. Outcomes of patient education in adult oncologic patients receiving oral anticancer agents: a systematic review protocol;Systematic Reviews;2023-04-20
5. Chemotherapy: how to reduce its adverse effects while maintaining the potency?;Medical Oncology;2023-02-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3